ConductScience.org, home

Paper32012154

SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy.

Ianevski A and 4 others. PLoS Comput Biol, 2020. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy. Papers, record 32012154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32012154

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy.
PubMed
Journal
PLoS Comput Biol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
2.21
iCite
Revised in PubMed
2020-05-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ianevski AAleksandr
2Timonen SSanna
3Kononov AAlexander
4Aittokallio TTerohttps://orcid.org/0000-0002-0886-9769
5Giri AKAnil Khttps://orcid.org/0000-0003-0941-1458

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Antiviral AgentsMajor topic
Drug CombinationsMajor topic
Hemorrhagic Fever, Ebola
High-Throughput Screening Assays
Humans
Neoplasms

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131141631Ibrutinib and Venetoclax for First-Line Treatment of CLL.N Engl J Med2019https://conductscience.org/library/papers/31141631PubMed
228804127Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.Leukemia2018https://conductscience.org/library/papers/28804127PubMed
329483097Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients.Cancer Res2018https://conductscience.org/library/papers/29483097PubMed
429245013Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy.Cell2017https://conductscience.org/library/papers/29245013PubMed
527438145Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia.Oncotarget2016https://conductscience.org/library/papers/27438145PubMed
628379339SynergyFinder: a web application for analyzing drug combination dose-response matrix data.Bioinformatics2017https://conductscience.org/library/papers/28379339PubMed
727723879Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results.JAMA Intern Med2016https://conductscience.org/library/papers/27723879PubMed
821532551Trial watch: Phase II failures: 2008-2010.Nat Rev Drug Discov2011https://conductscience.org/library/papers/21532551PubMed
927377132Combine and conquer: challenges for targeted therapy combinations in early phase trials.Nat Rev Clin Oncol2017https://conductscience.org/library/papers/27377132PubMed
1029017371Cytarabine and daunorubicin for the treatment of acute myeloid leukemia.Expert Opin Pharmacother2017https://conductscience.org/library/papers/29017371PubMed
1129939303Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures.J Infect Dis2018https://conductscience.org/library/papers/29939303PubMed
1226041706A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity.Sci Transl Med2015https://conductscience.org/library/papers/26041706PubMed
1421576426Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21576426PubMed
1524898935Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies.Sci Rep2014https://conductscience.org/library/papers/24898935PubMed
1631432301Genome-wide off-targets of drugs: risks and opportunities.Cell Biol Toxicol2019https://conductscience.org/library/papers/31432301PubMed
1727165605Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.Mol Cancer2016https://conductscience.org/library/papers/27165605PubMed
1828104689Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.Blood2017https://conductscience.org/library/papers/28104689PubMed
192692037What is synergy?Pharmacol Rev1989https://conductscience.org/library/papers/2692037PubMed
2024085192A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans.Toxicol Sci2014https://conductscience.org/library/papers/24085192PubMed
2126949479Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model.Comput Struct Biotechnol J2015https://conductscience.org/library/papers/26949479PubMed

See all 22 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42919347ComplexMatrixComb: predicting anticancer drug combination dosages for target growth inhibition via complex-number matrix factorization.J Cheminform2026https://conductscience.org/library/papers/42919347PubMed
42380246A review of deep learning approaches for drug synergy prediction in cancer.NPJ Drug Discov2025https://conductscience.org/library/papers/42380246PubMed
42307375Efficacy of selenium- and tellurium-based organocompounds against ruminant gastrointestinal nematodes in vitro.Rev Bras Parasitol Vet2026https://conductscience.org/library/papers/42307375PubMed
42185895Standardizing antiviral response metrics for mono- and combination therapies in acute, chronic and latent viral infections.Virol J2026https://conductscience.org/library/papers/42185895PubMed
42102151DeepDRP: Dose-response predictions of drug pairs using deep learning based on data-driven feature representation and dose-response curve characteristics.PLoS One2026https://conductscience.org/library/papers/42102151PubMed
41537239Characterizing clinical toxicity in cancer combination therapies.Bioinformatics2026https://conductscience.org/library/papers/41537239PubMed
41531664Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy.Hemasphere2026https://conductscience.org/library/papers/41531664PubMed
41397961An open-source screening platform accelerates discovery of drug combinations.Nat Commun2025https://conductscience.org/library/papers/41397961PubMed
40855143Preventing Preterm Birth: The Search for Tocolytic Synergism.Reprod Sci2025https://conductscience.org/library/papers/40855143PubMed
40234614Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.Leukemia2025https://conductscience.org/library/papers/40234614PubMed
40186177Exome-wide association study reveals 7 functional variants associated with ex-vivo drug response in acute myeloid leukemia patients.BMC Med Genomics2025https://conductscience.org/library/papers/40186177PubMed
39323620Bioinformatics Approaches in the Development of Antifungal Therapeutics and Vaccines.Curr Genomics2024https://conductscience.org/library/papers/39323620PubMed
39261955Challenges in validation of combination treatment strategies for CRC using patient-derived organoids.J Exp Clin Cancer Res2024https://conductscience.org/library/papers/39261955PubMed
39168097A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level.Cell Rep Med2024https://conductscience.org/library/papers/39168097PubMed
38227161Network-based drug repurposing identifies small molecule drugs as immune checkpoint inhibitors for endometrial cancer.Mol Divers2024https://conductscience.org/library/papers/38227161PubMed
38214879Prolymphocytic Leukaemia: an Update on Biology and Treatment.Curr Oncol Rep2024https://conductscience.org/library/papers/38214879PubMed
38097586Mapping combinatorial drug effects to DNA damage response kinase inhibitors.Nat Commun2023https://conductscience.org/library/papers/38097586PubMed
37268740Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach.Nat Rev Gastroenterol Hepatol2023https://conductscience.org/library/papers/37268740PubMed
36733367Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia.Front Oncol2022https://conductscience.org/library/papers/36733367PubMed
36713829A comprehensive tool for tumor precision medicine with pharmaco-omics data analysis.Front Pharmacol2023https://conductscience.org/library/papers/36713829PubMed

See all 33 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
SLC25A6293PubTator's text mininghttps://conductscience.org/library/genes/293NCBI Gene
SYNM23336PubTator's text mininghttps://conductscience.org/library/genes/23336NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32012154

GET https://conductscience.org/api/papers/v1/32012154/references?page=2